Brucker Benjamin M
NYU Langone Health New York, NY.
Rev Urol. 2018;20(4):170-173. doi: 10.3909/riu0822.
Nocturia is a condition that has a tremendous impact on a patient's health and wellbeing. Getting up 2 or more times a night to urinate fragments sleep, preventing deep, restorative stages of the sleep cycle. With safer and more effective therapies, nocturia is a treatable condition that no longer should be overlooked. The simplicity of directly targeting the cause of nocturia, the overproduction of urine (ie, nocturnal polyuria) should be considered. Noctiva™ (desmopressin acetate) nasal spray (Avadel Pharmaceuticals plc, Chesterfield, MO), a novel FDA-approved microdose desmopressin nasal spray, can reduce nighttime urine production and potentially mitigate the potential harm of nocturia.
夜尿症是一种对患者的健康和幸福有着巨大影响的病症。每晚起床排尿2次或更多次会破坏睡眠，妨碍睡眠周期中深度的、具有恢复作用的阶段。有了更安全、更有效的治疗方法，夜尿症是一种可治疗的病症，不应再被忽视。应考虑直接针对夜尿症病因——尿液产生过多（即夜间多尿）这一简单方法。Noctiva™（醋酸去氨加压素）鼻喷雾剂（位于密苏里州切斯特菲尔德的Avadel制药公司）是一种经美国食品药品监督管理局批准的新型微剂量去氨加压素鼻喷雾剂，可减少夜间尿量，并有可能减轻夜尿症的潜在危害。
